Definium succeeds in late-stage trial for LSD-derived psychiatric therapy
Phase 3positivePositive
AI Analysis
Summary
Definium announced positive Phase 3 trial results for its LSD-derived psychiatric therapy. The late-stage trial success represents a significant milestone for the psychedelic-based treatment program.
Clinical Trial Data
Phase
Phase 3
Primary Endpoint
Met
Importance:8/10
Sentiment:
0.80
Phase 3 successpsychiatrypsychedelicslate-stage trial
Read the original article
Published by Seeking Alpha Healthcare on August 12, 2026 11:56 AM